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The prevalence of quinolone-resistant Neisseria gonorrhoeae (QRNG) in Greece remained low from 1997
to 2003 but increased dramatically from 11% to 56% between 2004 and 2007. N. gonorrhoeae multiantigen
sequence typing (NG-MAST) and multilocus sequence typing (MLST) were used to investigate trends in
quinolone resistance from 1997 to 2007 and explore the origins of the recent increase in QRNG. We
characterized 295 QRNG isolates from the study period and 233 quinolone-susceptible (QS) gonococci
from 2004 and 2005, when the rapid increase in QRNG occurred. From 1997 to 1999, an outbreak of QRNG
was due to the dissemination of isolates of serovar Arst that belonged to two closely related genotypes. Few
QRNG isolates, of diverse genotypes, were present between 2001 and 2003, whereas the sharp increase in
QRNG from 2004 onwards was due to the appearance of serovar Bropyst isolates of several major
NG-MAST sequence type (STs) that previously had not been identified in Greece. These isolates were
shown by MLST to be variants of a single multiply antibiotic-resistant QRNG strain (ST1901) that
appeared in Greece and rapidly diversified into 31 NG-MAST STs. There were no isolates of MLST ST1901
or any of the 31 NG-MAST STs among QS isolates from 2004 and 2005 or among 8 representatives of
multiresistant but quinolone-susceptible serovar Bropyst isolates circulating in Greece during the 1990s,
supporting the view that the recent increase in QRNG was due to importation of a QRNG strain(s) of
MLST ST1901 into Greece. Recently, multiresistant QRNG isolates of ST1901 with reduced susceptibility
to the newer cephalosporins have appeared in Greece.
Resistance of Neisseria gonorrhoeae to fluoroquinolones has
become widespread, and in many countries these antibiotics
can no longer be used as the antibiotic of choice for uncom-
plicated gonorrhea (4, 5, 20). The Greek National Reference
Center for N. gonorrhoeae (NRCNG) has conducted continu-
ous surveillance of antimicrobial susceptibility trends since
1984 (24). NRCNG identified the first quinolone-resistant N.
gonorrhoeae (QRNG) strain in Greece in 1990, from a patient
infected in the Philippines (22). Gonococci with decreased
susceptibility to fluoroquinolones emerged in 1996. These iso-
lates had the Arst serovar, harbored the conjugative plasmid
but lacked the cryptic gonococcal plasmid, and displayed a
single restriction pattern on pulsed-field gel electrophoresis
(PFGE) (12). However, isolates of this clone, which persisted
up to 1999, exhibited resistance to nalidixic acid but only mar-
ginal nonsusceptibility to various fluoroquinolone compounds.
QRNG isolates that were highly resistant to fluoroquinolones
appeared again in 1997, initially as sporadic isolates but in
increasing frequencies between the years 2000 and 2003 (18).
Their prevalence has increased greatly since 2004, reaching a
peak of 56% of all gonococcal isolates in 2007 (21, 23).
The increase in QRNG between 1997 and 2007 and partic-
ularly between 2004 and 2007 could be due to the development
of resistance among quinolone-susceptible (QS) strains circu-
lating in Greece or to the importation and establishment of
resistant strains from other countries. Molecular typing can be
used to explore the basis of the emergence of QRNG strains,
and several methods have been used for typing gonococci (6, 9,
25). In recent years, sequence-based methods have been fa-
vored for molecular typing as they allow simple interlaboratory
comparisons of isolates. Perhaps the most widely used current
method of typing gonococci is multiantigen sequence typing
(NG-MAST), which indexes nucleotide sequence variations in
both porB and tbpB and assigns isolates to sequence types
(STs) on the basis of the alleles present at these two loci (9).
Gonococci that are assigned to the same NG-MAST ST
have identical sequences at both porB and tbpB. These genes
encode cell surface antigens that are subject to selective pres-
sures applied by the human immune response, and NG-MAST
STs are therefore likely to change relatively rapidly as gono-
coccal strains spread. Thus, a single gonococcal strain will
diversify rapidly into multiple NG-MAST STs by mutations (or
recombinational replacements), first in one gene and then in
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the other (9). The rapid rate of change of NG-MAST STs is
useful for short-term or fine-scale epidemiology (2), but for
following the spread of strains over a period of years, rapid
diversification can obscure the fact that several NG-MAST STs
may be minor variants of the same gonococcal strain.
Tracking the spread of gonococcal strains over longer time
periods requires the use of a typing method where the genetic
variation being indexed accumulates more slowly than that in
genes encoding cell surface antigens. This can be achieved by
multilocus sequence typing (MLST), which characterizes iso-
lates using the sequences of seven housekeeping genes (1, 8,
17), and can identify which of the NG-MAST STs among a set
of QRNG isolates are minor variants of the same strain.
Housekeeping genes of gonococci have relatively few polymor-
phic sites, and MLST is therefore not highly discriminatory for
gonococci (17). In this study, we used NG-MAST and made
selective use of MLST to investigate the emergence and rapid
recent increase of QRNG in Greece and provide evidence that
they were due to the importation and spread of a single strain.
MATERIALS AND METHODS
A total of 536 gonococci of known antibiotic susceptibility and serovar from
the collection of the NRCNG were studied. This sample included 295 out of 306
QRNG isolates that were submitted to the NRCNG during the period from 1997
to 2007, as well as 233 out of 239 QS isolates submitted in the years 2004 and
2005, during which the abrupt increase in the prevalence of QRNG isolates was
observed in Greece. The 17 missing isolates could not be recovered from storage.
Eight isolates representing the three most prevalent PFGE patterns among
multiresistant, but QS, serovar Bropyst gonococci were also included, one from
each of the years from 1996 to 2003. Antibiotic susceptibility testing and suscep-
tibility categorization of the isolates had been performed as described previously,
using the Etest and generally accepted criteria (18, 21). QRNG included all
isolates that exhibited resistance to nalidixic acid (ciprofloxacin MIC range, 0.047
to 32 mg/liter).
Molecular typing was performed using NG-MAST as described previously
(10). Alleles at porB and tbpB and NG-MAST STs were assigned at the NG-
MAST website (www.ng-mast.net). One isolate of each NG-MAST ST was also
characterized by MLST using the Neisseria MLST scheme hosted at www
.pubmlst.org. PCR amplification and sequencing of internal fragments of the
seven housekeeping loci were performed as described previously (1, 8), using the
following pairs of primers: abcZ-P1 (5-AATCGTTTATGTACCGCAGG-3)
and abcZ-S2 (5-GAGAACGAGCCGGGATAGGA-3), adk-UP (5-GGCATT
CCGCAAATCTCTAC-3) and adk-DN (5-GTGGGTACGACCTTTTCGAT-
3), aroE-UP (5-ACAGGAAGCGTTTCATCTGG-3) and aroE-DN (5-GGT
GATGATGTTGCCGTACA-3), fumC-UP (5-CCATCCCGAATACGCTGA-
3) and fumC-DN (5-TAGCGCGGATGAACCATATC-3), gdh-UP (5-GCA
AAGAAAGCCTGCAAAAC-3) and gdh-DN (5-TAAAGGCGGACGGATT
CAT-3), pdhC-UP (5-TTATGACCCGACCTTCCAATA-3) and pdhC-DN
(5-GGCTTTGATGCCGTATTTCT-3), and pgm-UP (5-CCTAATCACCAC
CCTGATCC-3) and pgm-DN (5-TTCAAAACGCAACACCAAAA-3). Al-
leles and MLST STs were assigned using the Neisseria MLST website (www
.pubmlst.org/neisseria). Alignments of the porB and tbpB nucleotide sequences
were performed using the MEGA software, version 4.0 (19), and the most likely
pathways between sequences were assessed by statistical parsimony, as imple-
mented in the TCS program (3).
RESULTS
Overview of QRNG isolates recovered between 1997 and
2007. The 306 QRNG isolates recovered between 1997 and
2007 were assigned to 29 different serovars, of which 8 included
at least five isolates (data not shown). Although none of these
serovars were represented exclusively by QRNG strains, 213 of
the QRNG isolates (70%) belonged to only two serovars, Arst
and Bropyst. The 295 QRNG isolates that were available for
further characterization were assigned to 84 NG-MAST STs,
12 of which included at least five isolates (Table 1). MLST was
carried out on one isolate of each of the 84 NG-MAST STs,
grouping them into 30 MLST STs. Assuming that all isolates of
the same NG-MAST ST belonged to the same MLST ST, the
12 major NG-MAST STs were grouped into 7 MLST STs
(Table 1). The numbers of QRNG isolates belonging to the 12
major NG-MAST STs and the 7 major MLST STs in each year
for the period from 1997 to 2007 are shown in Fig. 1 and 2. The
numbers of QRNG isolates of all NG-MAST STs in each year
and their corresponding MLST ST assignments are given in
Table S1 in the supplemental material.
QRNG isolates recovered between 1997 and 2003. Between
1997 and 1999, the majority of the QRNG isolates were sero-
var Arst, which corresponded to the serovar of an outbreak
strain that was circulating at the beginning of the sampling
period (12). The 30 serovar Arst QRNG isolates were assigned
by NG-MAST mostly to ST2594 (first identified in 1997), with
5 being ST2595 (first identified in 1998) (Table 1; Fig. 1). The
isolates of these two NG-MAST STs appear to be closely
related, as they had the same porB allele and differed only at
tbpB and they differed by MLST at only one of the seven loci
(MLST STs 8392 and 8393). As previously reported, these
isolates have only marginally decreased susceptibility to fluo-
roquinolones. Isolates of these NG-MAST STs were not found
after 1999 (Fig. 1; see Table S1 in the supplemental material).
Only 3 QRNG isolates, of two novel NG-MAST STs, were
identified in 2000, and the 31 isolates recovered from 2001 to
2003 were of diverse genotypes, with the exception of ST154
(serovar Bopyst), which was found five times in 2001 and three
times in 2002 but not subsequently (Fig. 1; see Table S1 in the
supplemental material).
TABLE 1. Major NG-MAST STs among QRNG isolated









154 87 33 1587 Bopyst 8 (2.7)
225 4 4 1901 Bropyst 29 (9.8)
289 234 4 1901 Bropst 1 (0.3)
289 234 4 1901 Bropyst 19 (6.4)
2616 1602 4 1901 Bopyst 1 (0.3)
2616 1602 4 1901 Bopyvst 1 (0.3)
2616 1602 4 1901 Bropst 1 (0.3)
2616 1602 4 1901 Bropyst 61 (20.7)
2618 1603 4 1901 Bropyst 10 (3.4)
2618 1603 4 1901 Brpst 1 (0.3)
3127 1901 110 1901 Bpyu 1 (0.3)
3127 1901 110 1901 Bpyut 6 (2.0)
3128 1900 110 1901 Bpyut 8 (2.7)
2265 1417 4 8110 Bpyvut 5 (1.7)
2265 1417 4 8110 Byvt 1 (0.3)
2265 1417 4 8110 Byvut 5 (1.7)
3348 1518 96 8129 Bropst 5 (1.7)
3348 1518 96 8129 Bropyst 2 (0.7)
2202 1382 4 8137 Bropyst 6 (2.0)
2594 947 165 8392 Arst 25 (8.5)
2595 947 33 8393 Arst 5 (1.7)
Subtotal 201 (68.1)
QRNG totala 295 (100.0)
a Includes NG-MAST STs that are not shown in the table, as they each
included less than five isolates.
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QRNG isolates recovered between 2004 and 2007. The in-
crease in prevalence of QRNG in Greece from 2004 to 2007
was associated with the emergence and spread of multiresis-
tant QRNG isolates of serovar Bropyst. From December 2006,
an additional cluster associated with quinolone resistance be-
gan to accumulate, consisting of multiresistant QRNG isolates
that exhibited the Bpyut serovar and reduced susceptibility to
the newer cephalosporins (21, 23). Molecular typing showed
that the rapid spread of the Bropyst isolates was due to the
appearance of a number of major NG-MAST STs of this se-
rovar (Fig. 1), including STs 225, 289, and 2616 and, to a lesser
extent, ST2618, whereas the multiresistant QRNG Bpyut iso-
lates were STs 3127 and 3128.
Characterization by MLST of one isolate of each NG-MAST
ST showed that all of the above NG-MAST STs were variants
of a single QRNG strain of MLST ST1901 (Table 2; Fig. 2).
Furthermore, 25 minor NG-MAST STs (each present between
2004 and 2007 as only one or two QRNG isolates) were also
MLST ST1901 (Table 2). Altogether, the isolates of the 31
NG-MAST STs that were assigned to MLST ST1901 included
76, 71, and 76% of all QRNG isolates characterized from the
years 2005, 2006, and 2007, respectively; 83% of these isolates
were serovar Bropyst.
The numbers of isolates assigned to the NG-MAST STs of
MLST ST1901 in each year are shown in Table 2. By 2004, STs
225, 289, and 2616 were all present and were recovered in all
subsequent years, with ST2616 increasing in prevalence each
year to represent 39% of all QRNG isolates in 2007. No iso-
lates of these STs were identified in 2003, although a single
isolate of ST289 was present in 2002. ST2618 was identified
FIG. 1. Number of isolates of gonococci of each NG-MAST ST submitted each year. The color coding for the major NG-MAST STs in the data
set is shown at the bottom. Isolates of minor NG-MAST STs are grouped together and shown as white in the histogram.
FIG. 2. Number of isolates of gonococci of each MLST ST submitted each year. The color coding for the major MLST STs in the data set is
shown at the bottom (NG-MAST STs are shown in parentheses). Isolates of minor MLST STs are grouped together and shown as white in the
histogram.
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only in 2005 and 2006. As mentioned, the QRNG isolates of
serovar Bpyut with reduced susceptibility to cephalosporins
that were assigned to NG-MAST STs 3127 and 3128 appeared
only in 2006.
Among the 31 NG-MAST STs of MLST ST1901, there were
25 porB and 9 tbpB alleles (Table 2). The alignment of the
nucleotide sequences revealed that there were 14 polymorphic
sites among 20 of the 25 porB alleles, and similarly, there were
5 polymorphic sites in 5 out of 9 tbpB alleles (data not shown).
The alignment of the concatenated sequences of porB and tbpB
from the 31 NG-MAST STs revealed that there were 17 poly-
morphic sites among 21 NG-MAST STs (data not shown). The
other 10 NG-MAST STs differed much more extensively in
either porB or tbpB.
Statistical parsimony analysis was performed for the concat-
enated porB-tbpB nucleotide sequences of 21 NG-MAST STs.
The NG-MAST STs with divergent sequences were excluded
from the analysis as they probably have arisen by recombina-
tional replacements rather than point mutations. The resulting
network is shown in Fig. 3. The TCS program assigns different
weights to each haplotype according to the haplotype fre-
quency in the sample, assuming that the most frequent haplo-
type is ancestral on the basis of coalescent theory. NG-MAST
ST2616 was the most frequent ST and was thus assigned to be
the putative ancestor (displayed as a square in the TCS dia-
gram). However, the assumption of ancestry on the basis of
frequency is problematic with gonococci, as individual geno-
types can increase in frequency rapidly if they enter dense
sexual networks.
An alternative approach is to consider the ST with the most
variants that differ by a single-step link to be the putative
ancestor. Using this criterion, NG-MAST ST289 was the pu-
tative ancestor, as it had the greatest number of single-step
links to other NG-MAST STs (five, plus two links to hypothet-
ical intermediate genotypes), including the most prevalent
NG-MAST ST (ST2616), which appeared in 2004. The sugges-
tion that NG-MAST ST289 may have been the ancestral ge-
notype introduced into Greece is consistent with the fact that
this was the genotype of the earliest QRNG isolate of MLST
ST1901. ST2616 linked directly to ST2618, the fourth most
prevalent NG-MAST ST, which appeared in 2005. There was
no single-step path from ST225 (the second most prevalent
NG-MAST ST, which appeared in 2004) to ST289 or to any of
the other prevalent STs. However, ST225 could have emerged
from ST289, as they differ only at two nucleotide sites, but we
cannot exclude the possibility of two separate introductions of
these NG-MAST STs of MLST ST1901 into the Greek gono-
coccal population.
Characterization of quinolone-susceptible isolates. QS
gonococci isolated in Greece during the period from 2004 to
2005 were studied, as it was within this period that the QRNG
strain defined by MLST ST1901 appeared and expanded. The
233 QS isolates were distributed into 36 MLST STs and 55
NG-MAST STs. Ten NG-MAST STs and eight MLST STs
included at least 5 isolates, and 117 of the 233 (50%) QS
isolates were either MLST ST1590 or ST8122 (Table 3; 7 of the
isolates of MLST ST1590 are not shown, as they were minor
NG-MAST STs). The great majority of the 46 MLST ST1590
isolates (85%) belonged to NG-MAST ST40, and all but 2 of
these were serovar Bpyust. Similarly, the great majority of
MLST ST8122 isolates (91%) corresponded to NG-MAST
ST210, and all but one of these were serovar Bpyvut (Table 3).
These two NG-MAST STs included 17% and 28% of all 233
QS isolates examined from 2004 to 2005, respectively.
Only one NG-MAST ST included both QS and QRNG
isolates (ST1979); all of these were from 2005, and only 1 of
the 10 isolates was QRNG. Five MLST STs included both QS
and QRNG isolates, and in all but one case the resistant and
susceptible isolates of the same MLST ST were different by
NG-MAST. Importantly, no isolates of the predominant
QRNG strain, MLST ST1901, or of any of the 31 NG-MAST
STs within MLST ST1901 were found among the QS isolates
from 2004 or 2005. Serovar Bropyst isolates with multiple
resistance to antibiotics other than quinolones were com-
monly recovered in Greece between 1991 and 1998 (11) and
could have been the QS progenitors of the recent QRNG
isolates of this serovar. The majority of these isolates
showed three different pulsed-field gel electrophoresis pat-
terns, and eight isolates representative of these patterns,
isolated between 1996 and 2003, were characterized by
MLST and NG-MAST; none of these were MLST ST1901
(data not shown).
TABLE 2. Distribution per year of QRNG isolates of NG-MAST







No. of isolates of each ST No. of
isolates2002 2004 2005 2006 2007
225 4 4 0 2 11 8 8 29
289 234 4 1 3 9 5 2 20
383 281 127 0 0 0 0 1 1
891 603 4 0 0 1 0 0 1
964 30 4 0 0 1 1 0 2
972 91 4 0 0 0 1 0 1
1365 876 4 0 0 1 1 0 2
1634 4 35 0 0 0 0 1 1
2616 1602 4 0 4 5 20 35 64
2618 1603 4 0 0 8 3 0 11
2619 234 35 0 0 1 0 0 1
2624 1604 321 0 1 0 0 0 1
2625 281 4 0 0 2 0 0 2
2628 1610 4 0 0 1 0 0 1
2694 4 25 0 0 0 0 1 1
2706 232 633 0 0 1 0 0 1
3056 1601 4 0 1 0 0 0 1
3127 1901 110 0 0 0 1 6 7
3128 1900 110 0 0 0 1 7 8
3150 1907 4 0 0 0 0 1 1
3163 4 708 0 0 0 0 1 1
3166 1919 4 0 0 0 0 2 2
3347 1690 4 0 0 0 1 0 1
3721 2253 4 0 0 0 1 0 1
3722 2254 4 0 0 0 1 0 1
3723 2255 4 0 0 0 2 0 2
3730 2246 4 0 0 0 1 0 1
3731 2251 4 0 0 0 1 0 1
3733 2252 4 0 0 0 0 1 1
3735 2249 4 0 0 0 0 1 1
3921 2252 854 0 0 0 0 1 1
Total 1 11 41 48 68 169
a NG-MAST STs represented by at least five isolates are denoted in boldface.
No isolates of NG-MAST STs assigned to MLST ST1901 were submitted in 2003.
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DISCUSSION
NG-MAST was developed as a typing tool to help identify
those individuals with gonorrhea within a local area who are in
the same sexual network (2, 9, 10). However, the method has
also been used, as it is here, to compare gonococcal isolates
recovered from different years across whole countries (7, 13,
14, 16, 26). The method has some drawbacks for this purpose,
as variant STs that differ at either porB or tbpB and then at
both loci will rapidly be generated. They can then no longer be
recognized as being minor variants of the same strain using
NG-MAST, but they can be by combining NG-MAST with the
selective use of MLST. The value of this approach was clearly
demonstrated in the present study, where MLST established
that the QRNG isolates assigned to all of the major NG-
MAST STs that appeared since 2004 were minor variants of a
single QRNG strain (MLST ST1901) that within 3 years had
diversified into 31 different NG-MAST STs.
The sudden increase in QRNG isolates since 2004 could
have been due to the importation and establishment of a quin-
olone-resistant isolate of MLST ST1901, with subsequent rapid
spread within Greece, or to the development of resistance to
quinolones among QS isolates already circulating within
Greece. Statistical parsimony provided some tentative support
for ST289 being the most likely ancestral QRNG NG-MAST
ST in Greece, which is consistent with the fact that it was
FIG. 3. Most likely evolutionary pathways between NG-MAST STs. Predicted pathways were obtained using statistical parsimony as imple-
mented in the TCS program (3). The prevalence of isolates of NG-MAST STs is shown by the size of the ovals and the square. The latter indicates
the predicted ancestral ST. Nucleotide substitutions between connected STs are indicated.
TABLE 3. Major NG-MAST STs among QS gonococci isolated












40 30 35 1590 Bpyust 37 (15.9)
40 30 35 1590 Brpyust 1 (0.4)
40 30 35 1590 Byust 1 (0.4)
495 91 32 1902 Boys 8 (3.4)
2609 1625 32 1902 Bropyst 4 (1.7)
2609 1625 32 1902 Broyst 1 (0.4)
1979 1264 4 7367 Bopyst 5 (2.1)
1979 1264 4 7367 Bropyst 4 (1.7)
2599 1164 60 8112 Bpyvut 8 (3.4)
943 640 29 8113 Bropt 5 (2.1)
2705 1614 321 8121 Broput 4 (1.7)
2705 1614 321 8121 Brput 1 (0.4)
210 59 4 8122 Bpyvut 64 (27.5)
210 59 4 8122 Byvut 1 (0.4)
2612 1628 4 8122 Bpyvut 6 (2.6)
654 3 29 8127 Brpyut 8 (3.4)
654 3 29 8127 Bryut 3 (1.3)
Subtotal 161 (69.1)
QS totala 233 (100)
a Includes NG-MAST STs that are not shown in the table, as they each
included less than five isolates.
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recognized 2 years before any of the other STs assigned to
MLST ST1901. Isolates of both STs 225 and 289 from coun-
tries outside Greece (e.g., England, France, and Scotland) are
already in the NG-MAST database (www.ng-mast.net) (2, 9,
10, 13, 16), whereas the three other STs that appeared in 2004
were novel and presumably arose within Greece.
There have been few studies of gonococci using MLST, as it
lacks sufficient discrimination to address many of the kinds of
epidemiological questions that arise with gonorrhea. Neverthe-
less, two isolates of ST1901, from South Korea and the United
Kingdom, have been deposited in the Neisseria MLST data-
base, although their dates of isolation are unclear. Interest-
ingly, QRNG isolates of MLST ST1901, which also exhibit
reduced susceptibility to cefixime, have been recovered in Ja-
pan from as early as 2000 (15; M. Ohnishi, personal commu-
nication). It is therefore possible that QRNG isolates of MLST
ST1901 had spread internationally by the early 2000s and were
first introduced into Greece from another country, subse-
quently spreading widely within Greece and diversifying into a
large number of novel NG-MAST STs. Importation is not
unlikely, given the large number of tourists that visit Greece
each year, and this scenario is supported by the failure to
identify QS isolates of MLST ST1901 in Greece in 2004 to
2005 or among multiresistant QS Bropyst isolates from 1996
to 2003 that could have been progenitors of the QRNG isolates
of this ST. Importation of QRNG isolates of MLST ST1901
into Greece in about 2002 therefore appears to be a more
likely possibility than the emergence of quinolone resistance
within gonococci already circulating in the country. Whatever
the source of the QRNG isolates of MLST ST1901, they have
subsequently spread very rapidly and are the major contributor
to the current high prevalence of quinolone resistance in
Greece. The appearance in late 2006 of the QRNG multire-
sistant NG-MAST ST3127 and ST3128 variants of MLST
ST1901 that also have decreased susceptibility to the newer
cephalosporins currently used for treatment of gonorrhea is of
concern and needs close monitoring.
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